Last 7 days
4.4%
Last 30 days
17.4%
Last 90 days
-20.5%
Trailing 12 Months
56.0%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 68.0M | 72.5M | 77.3M | 0 |
2022 | 54.1M | 57.7M | 62.4M | 64.4M |
2021 | 19.3M | 31.9M | 39.8M | 48.0M |
2020 | 0 | 0 | 0 | 11.8M |
2019 | 0 | 0 | 0 | 0 |
2018 | 8.6M | 9.0M | 1.5M | 1.1M |
2017 | 15.2M | 12.8M | 10.5M | 8.2M |
2016 | 0 | 0 | 0 | 17.5M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Aug 31, 2023 | smith jason drew | acquired | - | - | 8,334 | general counsel |
Aug 31, 2023 | smith jason drew | sold | -68,438 | 18.01 | -3,800 | general counsel |
Jul 26, 2023 | cohen fred e | acquired | 661,494 | 9.54 | 69,339 | - |
Jan 31, 2023 | schoenberg mark | acquired | - | - | 3,833 | chief medical officer |
Jan 31, 2023 | barrett elizabeth a. | acquired | - | - | 18,333 | chief executive officer |
Jan 31, 2023 | smith jason drew | sold | -16,556 | 10.12 | -1,636 | general counsel |
Jan 31, 2023 | smith jason drew | acquired | - | - | 3,333 | general counsel |
Jan 31, 2023 | schoenberg mark | sold | -19,228 | 10.12 | -1,900 | chief medical officer |
Jan 20, 2023 | schoenberg mark | acquired | 613,385 | 5.00 | 122,677 | chief medical officer |
Oct 31, 2022 | schoenberg mark | acquired | - | - | 500 | chief medical officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Nov 24, 2023 | DEUTSCHE BANK AG\ | added | 666 | 133,111 | 147,301 | -% |
Nov 15, 2023 | MORGAN STANLEY | added | 76.52 | 905,326 | 1,556,890 | -% |
Nov 15, 2023 | Opaleye Management Inc. | reduced | -43.86 | -1,416,300 | 4,483,200 | 1.46% |
Nov 15, 2023 | GSA CAPITAL PARTNERS LLP | new | - | 143,000 | 143,000 | 0.01% |
Nov 15, 2023 | Annandale Capital, LLC | reduced | -2.96 | 273,000 | 1,146,000 | 0.28% |
Nov 15, 2023 | JANE STREET GROUP, LLC | reduced | -24.69 | 2,675 | 140,899 | -% |
Nov 14, 2023 | WELLINGTON MANAGEMENT GROUP LLP | new | - | 981,582 | 981,582 | -% |
Nov 14, 2023 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -33.67 | -6,877 | 60,481 | -% |
Nov 14, 2023 | LAZARD ASSET MANAGEMENT LLC | new | - | 46,000 | 46,000 | -% |
Nov 14, 2023 | MILLENNIUM MANAGEMENT LLC | added | 43.54 | 1,875,220 | 3,863,750 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Sep 15, 2023 | great point partners llc | 8.51% | 2,620,545 | SC 13G | |
Aug 04, 2023 | monograph capital holdings advisors, llc | 5.1% | 1,572,327 | SC 13D | |
Jun 12, 2023 | menora mivtachim holdings ltd. | 12.45% | 2,919,002 | SC 13G/A | |
Feb 13, 2023 | stonepine capital management, llc | 5.7% | 1,304,947 | SC 13G/A | |
Dec 01, 2022 | stonepine capital management, llc | 5.2% | 1,196,908 | SC 13G | |
Jul 08, 2022 | blackrock inc. | 1.5% | 340,412 | SC 13G | |
Feb 14, 2022 | wildcat capital management, llc | 2.4% | 533,139 | SC 13G/A | |
Feb 14, 2022 | credit suisse ag/ | 4.84% | 1,085,749 | SC 13G/A | |
Feb 04, 2022 | wellington management group llp | 1.06% | 238,008 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 7.7% | 1,728,094 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Nov 14, 2023 | 10-Q | Quarterly Report | |
Nov 14, 2023 | 8-K | Current Report | |
Nov 14, 2023 | S-8 | Employee Benefits Plan | |
Sep 15, 2023 | EFFECT | EFFECT | |
Sep 15, 2023 | SC 13G | Major Ownership Report | |
Sep 13, 2023 | CORRESP | CORRESP | |
Sep 12, 2023 | UPLOAD | UPLOAD | |
Sep 11, 2023 | 8-K | Current Report | |
Sep 08, 2023 | 4 | Insider Trading | |
Sep 08, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HILS | 31.4B | - | 4.92% | 426363.59% | -3.6K | 218.4K | - | -102.45% |
MRNA | 30.7B | 10.7B | 11.84% | -53.56% | -8.86 | 2.88 | -53.67% | -129.46% |
ALNY | 22.0B | 1.7B | 4.71% | -20.32% | -43.06 | 12.74 | 79.37% | 56.87% |
BMRN | 17.7B | 2.3B | 23.54% | -7.88% | 120.62 | 7.68 | 15.05% | 75.21% |
INCY | 12.4B | 3.6B | 1.56% | -32.86% | 29.22 | 3.44 | 8.35% | -51.49% |
MID-CAP | ||||||||
APLS | 7.5B | 272.9M | 38.55% | 34.32% | -12.3 | 27.31 | 141.38% | 4.43% |
BBIO | 5.6B | - | 16.25% | 246.63% | -9.66 | 48.33 | 54.84% | -12.96% |
ACAD | 3.5B | 631.9M | -10.80% | 43.56% | -23.57 | 5.55 | 23.54% | 31.53% |
AXSM | 3.3B | 223.4M | 11.07% | -7.88% | -16.25 | 14.68 | - | -26.24% |
ARWR | 2.6B | 240.7M | -11.66% | -25.68% | -12.44 | 10.6 | -1.03% | -16.59% |
SMALL-CAP | ||||||||
CPRX | 1.5B | 348.4M | 7.85% | -14.88% | 24.07 | 4.29 | 81.69% | -7.29% |
NVAX | 662.5M | 1.0B | -19.01% | -66.75% | -1.21 | 0.63 | -43.15% | 58.48% |
INO | 100.5M | 6.4M | -2.56% | -78.77% | -0.61 | 15.6 | -44.11% | 50.48% |
IBIO | 42.3M | - | 410.00% | -4.38% | -0.65 | - | - | -29.23% |
CRBP | 26.3M | - | 17.86% | 4717.52% | -0.55 | - | - | -13.74% |
Income Statement (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | -1.4% | 20,852,000 | 21,139,000 | 17,192,000 | 18,092,000 | 16,097,000 | 16,604,000 | 13,564,000 | 16,174,000 | 11,351,000 | 13,032,000 | 7,485,000 | 7,966,000 | 3,461,000 | 372,000 | 310,000 | 248,000 | 186,000 | 124,000 | 62,000 | - | 283,000 |
Cost Of Revenue | -3.1% | 2,367,000 | 2,443,000 | 2,265,000 | 2,263,000 | 2,020,000 | 1,846,000 | 1,525,000 | 1,589,000 | 1,244,000 | 1,427,000 | 897,000 | 652,000 | 309,000 | 48,000 | - | - | - | - | - | - | 1,055,000 |
Gross Profit | -1.1% | 18,485,000 | 18,696,000 | 14,927,000 | 15,829,000 | 14,077,000 | 14,758,000 | 12,039,000 | 14,585,000 | 10,107,000 | 11,605,000 | 6,588,000 | 7,314,000 | 3,152,000 | 324,000 | - | - | - | 18,000 | - | - | -772,000 |
S&GA Expenses | -3.3% | 21,755,000 | 22,494,000 | 24,474,000 | 21,634,000 | 19,071,000 | 20,833,000 | 21,300,000 | 21,418,000 | 21,624,000 | 22,304,000 | 22,189,000 | 22,163,000 | 22,065,000 | 24,018,000 | 21,973,000 | 19,745,000 | 13,972,000 | 13,775,000 | 12,707,000 | 12,552,000 | 10,743,000 |
R&D Expenses | -11.7% | 10,230,000 | 11,584,000 | 12,498,000 | 14,477,000 | 13,093,000 | 12,640,000 | 12,696,000 | 13,082,000 | 11,923,000 | 12,124,000 | 10,513,000 | 12,405,000 | 10,211,000 | 8,106,000 | 16,588,000 | 20,094,000 | 9,481,000 | 9,996,000 | 9,726,000 | 11,465,000 | 9,574,000 |
EBITDA Margin | - | - | - | -1.61 | -1.66 | -1.70 | -1.93 | -2.05 | -2.26 | -2.72 | -3.36 | -6.20 | -10.14 | -14.99 | -80.63 | -76.24 | -76.32 | -53.65 | - | - | - | - |
Income Taxes | -116.7% | -9,000 | 54,000 | 21,000 | 689,000 | 709,000 | 32,000 | 325,000 | 1,137,000 | - | 312,000 | - | 3,374,000 | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 9.1% | -21,888,000 | -24,082,000 | -30,192,000 | -28,180,000 | -25,122,000 | -26,659,000 | -28,067,000 | -27,315,000 | -30,211,000 | -25,910,000 | -25,935,000 | -27,152,000 | -28,816,000 | -31,349,000 | - | - | - | - | - | - | - |
EBT Margin | - | - | - | -1.62 | -1.68 | -1.72 | -1.95 | -2.06 | -2.28 | -2.74 | -3.38 | -6.49 | -10.60 | -15.70 | -84.27 | -80.39 | -80.39 | -57.75 | - | - | - | - |
Net Income | 9.4% | -21,879,000 | -24,136,000 | -30,213,000 | -28,869,000 | -25,831,000 | -26,691,000 | -28,392,000 | -28,452,000 | -30,211,000 | -26,222,000 | -25,935,000 | -30,526,000 | -28,816,000 | -31,349,000 | -37,793,000 | -38,973,000 | -22,252,000 | -22,477,000 | -21,444,000 | -23,716,000 | -20,533,000 |
Net Income Margin | - | - | - | -1.64 | -1.71 | -1.75 | -1.97 | -2.09 | -2.31 | -2.83 | -3.49 | -6.05 | -10.89 | -17.86 | -87.61 | -92.89 | -80.39 | -68.72 | - | - | - | - |
Free Cashflow | - | - | - | -25,830,000 | -21,765,000 | -17,765,000 | -24,262,000 | -24,021,000 | -20,272,000 | -18,670,000 | -19,014,000 | -27,688,000 | -21,414,000 | -25,740,000 | -24,216,000 | -35,731,000 | -26,192,000 | -12,577,000 | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | 103.1% | 194 | 95.00 | 113 | 136 | 128 | 146 | 166 | 120 | 135 | 154 | 97.00 | 122 | 140 | 161 | 167 | 202 | 227 | 239 | 252 | 104 | 113 |
Current Assets | 123.9% | 182 | 81.00 | 96.00 | 129 | 122 | 140 | 161 | 114 | 125 | 140 | 93.00 | 116 | 129 | 130 | 122 | 149 | 160 | 191 | 248 | 102 | 111 |
Cash Equivalents | 492.8% | 119 | 20.00 | 37.00 | 55.00 | 29.00 | 81.00 | 105 | 44.00 | 55.00 | 63.00 | 40.00 | 53.00 | 25.00 | 36.00 | 26.00 | 50.00 | 66.00 | 90.00 | 247 | 101 | 109 |
Inventory | 0.3% | 5.00 | 5.00 | 5.00 | 4.00 | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 | 3.00 | 3.00 | 2.00 | 1.00 | 1.00 | - | - | - | - | - | - | - |
Net PPE | -9.6% | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | 0.8% | 236 | 234 | 230 | 225 | 192 | 187 | 183 | 111 | 103 | 97.00 | 21.00 | 26.00 | 19.00 | 18.00 | 16.00 | 22.00 | 16.00 | 14.00 | 12.00 | 13.00 | 9.00 |
Current Liabilities | -3.7% | 26.00 | 27.00 | 25.00 | 24.00 | 19.00 | 18.00 | 19.00 | 22.00 | 20.00 | 19.00 | 17.00 | 21.00 | 18.00 | 16.00 | 14.00 | 19.00 | 14.00 | 12.00 | 10.00 | 13.00 | 9.00 |
LT Debt, Non Current | 0.2% | 99.00 | 98.00 | 98.00 | 98.00 | 72.00 | 71.00 | 71.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | 69.7% | -41.99 | -138 | - | -89.36 | -63.29 | -40.91 | - | 8.00 | 32.00 | 56.00 | 76.00 | 96.00 | 121 | 143 | 150 | 180 | 211 | 225 | 240 | 90.00 | 104 |
Retained Earnings | -3.5% | -653 | -631 | -607 | -577 | -548 | -522 | -495 | -467 | -438 | -408 | -382 | -356 | -326 | -297 | -265 | -228 | -189 | -166 | -144 | -122 | -99.15 |
Additional Paid-In Capital | 24.0% | 611 | 493 | 491 | 488 | 485 | 481 | 479 | 476 | 470 | 465 | 459 | 453 | 446 | 439 | 416 | 408 | 400 | 391 | 384 | 213 | 203 |
Shares Outstanding | 31.5% | 31.00 | 24.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 21.00 | 21.00 | 21.00 | 20.00 | 21.00 | 19.00 | 16.00 | 16.00 |
Cashflow (Quarterly) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | 14.7% | -17,299 | -20,274 | -25,807 | -21,752 | -17,612 | -24,199 | -23,996 | -20,070 | -18,476 | -18,945 | -27,401 | -21,242 | -25,080 | -23,929 | -35,635 | -26,000 | -12,528 | -14,555 | -17,934 | -10,284 | -9,279 |
Share Based Compensation | 0.1% | 2,224 | 2,222 | 2,286 | 2,368 | 2,440 | 2,823 | 2,949 | 5,357 | 5,515 | 6,046 | 6,195 | 6,526 | 6,763 | 7,119 | 7,617 | 8,065 | 7,243 | 7,212 | 7,447 | 8,877 | 9,515 |
Cashflow From Investing | -89.2% | 401 | 3,720 | 6,270 | 23,108 | -35,493 | -151 | 13,596 | 9,125 | 10,660 | -30,740 | 15,024 | 49,465 | 13,234 | 17,514 | 13,025 | 9,296 | -12,659 | -142,186 | -44.00 | -26.00 | -333 |
Cashflow From Financing | 81072.7% | 116,077 | 143 | 671 | 25,368 | 1,101 | -77.00 | 70,742 | -32.00 | -168 | 72,515 | 4.00 | 78.00 | 61.00 | 16,298 | 90.00 | 245 | 1,126 | 373 | 163,506 | 2,200 | -14.00 |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Revenue | $ 20,852 | $ 16,097 | $ 59,183 | $ 46,265 |
Cost of revenue | 2,367 | 2,020 | 7,075 | 5,391 |
Gross profit | 18,485 | 14,077 | 52,108 | 40,874 |
Operating expenses: | ||||
Research and development expenses | 10,230 | 13,093 | 34,312 | 38,429 |
Selling, general and administrative expenses | 21,755 | 19,071 | 68,723 | 61,204 |
Operating loss | (13,500) | (18,087) | (50,927) | (58,759) |
Financing on prepaid forward obligation | (5,479) | (4,819) | (16,047) | (16,478) |
Interest expense on long-term debt | (3,815) | (2,694) | (11,129) | (5,215) |
Interest and other income, net | 906 | 478 | 1,941 | 604 |
Loss before income taxes | (21,888) | (25,122) | (76,162) | (79,848) |
Income tax expense | 9 | (709) | (66) | (1,066) |
Net Loss | (21,879) | (25,831) | (76,228) | (80,914) |
Statements of Comprehensive Loss | ||||
Net loss | (21,879) | (25,831) | (76,228) | (80,914) |
Other comprehensive income (loss) | ||||
Unrealized gain (loss) on investments | 20 | (99) | (27) | (130) |
Comprehensive Loss | $ (21,859) | $ (25,930) | $ (76,255) | $ (81,044) |
Net loss per ordinary share - basic and diluted (in dollars per share) | $ (0.68) | $ (1.13) | $ (2.89) | $ (3.56) |
Weighted average number of shares outstanding used in computation of basic and diluted loss per ordinary share (in shares) | 32,298,182 | 22,798,263 | 26,358,719 | 22,711,686 |
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 119,305 | $ 55,408 |
Marketable securities | 28,114 | 44,556 |
Restricted cash | 817 | 813 |
Accounts receivable | 12,847 | 12,704 |
Inventories | 5,002 | 4,325 |
Prepaid expenses and other current assets | 16,038 | 11,101 |
Total current assets | 182,123 | 128,907 |
Non-current assets: | ||
Property and equipment, net | 823 | 1,297 |
Restricted deposit | 225 | 223 |
Right of use assets | 1,905 | 2,452 |
Marketable securities | 6,507 | 0 |
Other non-current assets | 2,050 | 2,740 |
Total Assets | 193,633 | 135,619 |
Current liabilities: | ||
Accounts payable and accrued expenses | 14,083 | 12,383 |
Employee related accrued expenses | 8,152 | 8,257 |
Other current liabilities | 3,553 | 3,276 |
Total current liabilities: | 25,788 | 23,916 |
Non-current liabilities: | ||
Prepaid forward obligation | 107,276 | 98,923 |
Long-term debt | 98,518 | 97,537 |
Long-term lease liabilities | 1,026 | 1,586 |
Uncertain tax positions liability | 3,018 | 3,018 |
Total Liabilities | 235,626 | 224,980 |
Commitments and Contingencies (Note 18) | ||
Shareholders' Deficit: | ||
Ordinary shares, NIS 0.01 par value, 100,000,000 shares authorized at September 30, 2023 and December 31, 2022; 30,854,778 and 23,129,953 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively | 84 | 63 |
Additional paid-in capital | 611,389 | 487,787 |
Accumulated deficit | (653,332) | (577,104) |
Accumulated other comprehensive loss | (134) | (107) |
Total Shareholders' Deficit | (41,993) | (89,361) |
Total Liabilities and Shareholders' Deficit | $ 193,633 | $ 135,619 |
CEO | Ms. Elizabeth A. Barrett |
---|---|
WEBSITE | www.urogen.com |
EMPLOYEES | 193 |